Domov › Steatotické ochorenie pečene › Florida

Klinické štúdie Steatotické ochorenie pečene v štáte Florida

20 štúdií pre Steatotické ochorenie pečene hľadá účastníkov v zariadeniach v štáte Florida.

Mestá v štáte Florida

Oficiálny text štúdie (anglicky)

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Ocala

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07704892

A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

GSK Investigational Site, Miami
GSK Investigational Site, Miami
GSK Investigational Site, Ocala

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07701993

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Health Awareness, Inc, Jupiter
Evolution Clinical Trials, Miami

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07527910

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

University of Miami Health System, Miami

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT05832229

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Evolution Clinical Trials, Hialeah Gardens
Health Awareness, inc., Jupiter
Genoma Research Group, Inc., Miami
a 2 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

K2 Medical Research WINTER GARDEN, Clermont
K2 Medical Research - Daytona Beach, Daytona Beach
Care Access - Delray Beach, Delray Beach
a 20 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Akero Clinical Study Site, Bradenton
Akero Clinical Study Site, Brandon
Akero Clinical Study Site, Cutler Bay
a 23 ďalších

Prebieha náborFáza 3

Vek 18 až 80 · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site, Boynton Beach
GSK Investigational Site, Cape Coral
GSK Investigational Site, Clermont
a 19 ďalších

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Synergy Healthcare, Bradenton
Synergy Healthcare, Bradenton
Health Awareness, Inc., Jupiter
a 6 ďalších

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07288138

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

89bio Clinical Study Site, Brandon
89bio Clinical Study Site, Clermont
89bio Clinical Study Site, Fort Myers
a 15 ďalších

Prebieha náborFáza 3

Vek 18 až 80 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

89bio Clinical Study Site, Clermont
89bio Clinical Study Site, Fort Myers
89bio Clinical Study Site, Gainesville
a 15 ďalších

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT06419374

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

AdventHealth Translational Research Institute, Orlando

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 25 až 55 · Všetky pohlavia · Aktualizované 12. 8. 2026 · NCT06993454

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

GSK Investigational Site, Brandon
GSK Investigational Site, Miami
GSK Investigational Site, Miami Lakes

Prebieha náborFáza 2

Vek 18 až 70 · Všetky pohlavia · Aktualizované 3. 8. 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site, Boynton Beach
GSK Investigational Site, Cape Coral
GSK Investigational Site, Clermont
a 20 ďalších

Prebieha náborFáza 3

Vek 18 až 75 · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT07221227

A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

GSK Investigational Site, Miami
GSK Investigational Site, Viera

Prebieha náborFáza 2

Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 7. 2026 · NCT06920043

A Study of Efimosfermin Alfa in Adults With Hepatic Impairment

GSK Investigational Site, Tampa

Prebieha náborFáza 1

Vek 18 až 70 · Všetky pohlavia · Aktualizované 9. 6. 2026 · NCT07358546

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Genoma Research Group, Inc, Miami
Med Research of Florida, LLC, Miami

Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov

Vek 18 až 75 · Všetky pohlavia · Aktualizované 16. 4. 2026 · NCT05648214

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

Clinical Pharmacology of Miami, Miami

Prebieha náborObservačná štúdia

Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 8. 2025 · NCT07122700

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

University of Florida, Gainesville

Prebieha náborFáza 2

Vek 21 až 75 · Všetky pohlavia · Aktualizované 4. 4. 2025 · NCT04501406

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

AdventHealth Translational Research Institute, Orlando

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 3. 2025 · NCT04807868

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.